You are using an outdated browser. Please upgrade your browser to improve your experience and security.

JazzCares
Patient support hotline 1-855-593-3955 1-855-593-3955 available Monday through Friday, 9 AM to 8 PM ET

Dedicated reimbursement specialists are available to assist with reimbursement for VYXEOS

Verification of coverage and reimbursement support

JazzCares specialists will:

  • Investigate benefits and verify patients' insurance coverage
  • Provide prior authorization and appeals support
  • Answer coding and other reimbursement questions
  • Refer patients to financial assistance options
Patient assistance program
(free-drug program for eligible patients)
  • Uninsured patients must have a total household gross income less than 400% of the federal poverty level
  • Patients must be legal US residents who have no coverage for VYXEOS or have insurance coverage but are deemed uninsured due to lack of coverage (ie, underinsured) for VYXEOS
  • Patients must have a prescription for VYXEOS from a physician licensed in the United States

Insurance coverage and plans may vary. The JazzCares program provides general information only and is not a guarantee of any coverage or reimbursement outcome. All treatment decisions rest solely with the treating physician or qualified healthcare professional.

Healthcare providers may request to be contacted by a Jazz Access and Reimbursement Manager (ARM) for assistance with additional reimbursement-related questions.

INDICATION

VYXEOS (daunorubicin and cytarabine) liposome for injection 44 mg/100 mg is indicated for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

IMPORTANT SAFETY INFORMATION

INDICATION

VYXEOS (daunorubicin and cytarabine) liposome for injection 44 mg/100 mg is indicated for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

Important Safety Information

WARNING: DO NOT INTERCHANGE WITH OTHER DAUNORUBICIN AND/OR CYTARABINE-CONTAINING PRODUCTS

VYXEOS has different dosage recommendations than daunorubicin hydrochloride injection, cytarabine injection, daunorubicin citrate liposome injection, and cytarabine liposome injection. Verify drug name and dose prior to preparation and administration to avoid dosing errors.